ArticleFrontiers in pharmacology2025

Structure-based identification of Jervine as a potent dual-targeting inhibitor of cell cycle kinases.

Md Nayab Sulaimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.